InsidersTradesSigma
Follow the PHARMANUTRA CS share price and the full insider trade history of the company, a listed equity based in Italy. Shares are quoted on the IT market, under the oversight of Consob. Operating in the Health Care sector, PHARMANUTRA CS has logged 1 public disclosures. Market capitalisation: €804.3m. The latest transaction was reported on 24 July 2024 (Other). All data is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 8,439 of 29,052 companies
61.9
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.6%
EV/EBITDA23.5x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2024
About PHARMANUTRA CS
PHARMANUTRA CS is a company operating in the health and pharmaceutical sector, listed on the XMIL market. It focuses on the development and marketing of nutraceutical and pharmaceutical products.